Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants-Reference-Cited by-同舟云学术

Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants

Published:2016-08-18 Issue:8 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

More Kiran¹²,Athalye-Jape Gayatri K³,Rao Shripada C⁴,Patole Sanjay K⁵

Affiliation:

1. Christchurch Women's Hospital; Department of Neonatology; Canterbury New Zealand

2. University of Otago; Dunedin New Zealand

3. Princess Margaret Hospital and King Edward Hospital; Department of Neonatology; Roberts Road Subiaco Western Australia Australia 6008

4. King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children; Centre for Neonatal Research and Education; Perth, Western Australia Australia 6008

5. King Edward Memorial Hospital; School of Paediatrics and Child Health, School of Women's and Infant's Health, University of Western Australia; 374 Bagot Rd Subiaco Perth Western Australia Australia 6008

Publisher

Wiley

Subject

Pharmacology (medical)

Reference56 articles.

1. A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn;Mohamed;Journal of Perinatology,2012

2. NCT01389856: Persistent Pulmonary Hypertension of the Newborn (FUTURE 4) https://clinicaltrials.gov/ct2/show/results/NCT01389856?sect=X01256#all

3. Steinhorn R Kusic-Pajic A Cornelisse P Fineman J Gehin M Nowbakht P Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: Results of the FUTURE-4 study Circulation: American Heart Association's 2014 Scientific Sessions and Resuscitation Science Symposium Chicago, IL United States 2014

4. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn;Abman;Neonatology,2007

5. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension;Abman;Annual Review of Medicine,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of pulmonary hypertension in infants;Expert Opinion on Orphan Drugs;2024-07-27

2. Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?*;Critical Care Medicine;2024-05-16

3. Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants;Expert Opinion on Pharmacotherapy;2023-09-14

4. Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis;Frontiers in Cardiovascular Medicine;2023-01-11

5. Review on Prevention of Cerebral Palsy from the Perspective of Social Pediatrics;Turkish Archives of Pediatrics;2022-10-25